In 2001, Vertex Pharmaceuticals Incorporated acquired the biotech company based in San Diego, Aurora Biosciences. The combination of technologies and Aurora Vertex improve the flow of new drug candidates in development. However, several issues related to the integration of Vertex Aurora remained outstanding, the most urgent being important collaboration of the Aurora with the Cystic Fibrosis Foundation (CFF). They were venture philanthropy and the foundation provides funding mechanism appropriate for a public company like Vertex? How does the board of Vertex and SBB could fundamentally align the goals of a for-profit company with a nonprofit institution work? These are the questions facing leaders Vertex.
by
Robert F. Higgins,
Brent Kazan
Source: Harvard Business School
27 pages.
Release Date: October 15, 2007. Prod #: 808005-PDF-ENG
Vertex Pharmaceuticals and the Cystic Fibrosis: Venture Philanthropy Funds for the settlement of cases Biotech
Related Case Solutions:
Gucci Group: Freedom within the Framework
Beroni Group: Managing GP- LP Relationships
Wilshire Sports Importers Ltd.
Introduction to Islamic Finance
Universal Display Corporation: Go Long or Short?
Time-Driven Activity-Based Costing
PayPal Merchant Services
WBS project network
The Pebble Mine (G): Wild Salmon Center
David Dunwood